Over dinner in Davos, the CEOs of Novartis, Coca-Cola, and Grab shared what’s worrying them
- ByFortune-
Highlights from Fortune's dinner in Davos.
Highlights from Fortune's dinner in Davos.
Newark, New Castle, USA, Feb. 01, 2023 (GLOBE NEWSWIRE) -- The global "Critical Care Antiarrhythmic Drugs Market Size" is expected to rise with an impressive CAGR and generate...
By Scott Kanowsky Investing.com -- European equities were mixed on Wednesday but widely held near the flatline, as investors awaited the highly anticipated release of the Federal...
EU attempting to revive Iran nuclear deal with market staying pessimistic Crude prices could rebound from oversold conditions but stay off 2022 highs Both Iran, US likely looking...
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally. The company operates through two segments: Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and physicians. It also provides cardiovascular, ophthalmology, neuroscience, immunology, hematology, and solid tumor products. The Sandoz segment develops, manufactures, and markets finished dosage forms of small molecule pharmaceuticals to third parties. It also provides protein- or other biotechnology-based products, including biosimilars; and biotechnology manufacturing services; and anti-infectives, such as active pharmaceutical ingredients and intermediates primarily antibiotics. Novartis AG has a license and collaboration agreement with Alnylam Pharmaceuticals to develop, manufacture, and commercialize inclisiran, a therapy to reduce LDL cholesterol. Novartis AG was incorporated in 1996 and is headquartered in Basel, Switzerland.
| Average | 94.94 (+19.73% Upside) |
| High | 114.1056 |
| Low | 71.1671 |
| Price | 79.30 |
| No. of Analysts | 20 |
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Strong Sell | Strong Sell | Sell | Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 126.00 | 126.00 | 124.00 | +2.00 | +1.61% | 1.23M | Philippines | |||
| 1.54 | 1.56 | 1.49 | +0.04 | +2.67% | 78.08M | Philippines | |||
| 108.50 | 108.50 | 105.50 | +1.60 | +1.50% | 828.74K | Philippines | |||
| 714.00 | 722.50 | 708.00 | +4.00 | +0.56% | 274.04K | Philippines | |||
| 4.15 | 4.23 | 4.15 | 0.00 | 0.00% | 36.86M | Philippines | |||
| 29.20 | 29.75 | 29.15 | +0.150 | +0.52% | 8.43M | Philippines | |||
| 37.70 | 38.05 | 37.50 | -0.10 | -0.26% | 2.01M | Philippines | |||
| 12.72 | 12.88 | 12.40 | +0.40 | +3.25% | 8.55M | Philippines | |||
| 1.46 | 1.47 | 1.45 | 0.00 | 0.00% | 914.00K | Philippines | |||
| 6.87 | 7.00 | 6.82 | +0.020 | +0.29% | 65.50K | Philippines | |||
| 11.90 | 12.06 | 11.62 | +0.180 | +1.54% | 11.71M | Philippines | |||
| 0.76 | 0.78 | 0.76 | -0.010 | -1.30% | 133.00K | Philippines | |||
| 54.00 | 54.50 | 53.45 | +0.100 | +0.19% | 1.02M | Philippines | |||
| 1.05 | 1.06 | 1.03 | +0.010 | +0.96% | 166.00K | Philippines | |||
| 8.10 | 8.35 | 7.90 | +0.300 | +3.85% | 581.30K | Philippines |